CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Improvement of quality of life in patients with bone pain in advanced cancer: reinforcing the role of radionuclide therapy for bone pain palliation

Author: 
Vandana Kumar Dhingra, Mohit Dhingra, Ashutosh Pandey, Ranjeeta Kumari and Nisha Bhatia
Subject Area: 
Health Sciences
Abstract: 

Context: Patients with multiple bone pains due to metastatic cancer in bones presenting in the clinic are very challenging for all oncologists. Along with conventional medical and interventional techniques, the option of radioisotopes for bone pain palliation especially in the multiple bone pain setting is not very popular. Aims: We describe our initial clinical experience with Sm-153 EDTMP in a tertiary care centre set in a hilly state and briefly review the potential of radioisotope methods for bone pain palliation in such a setting. Settings and Design: Initial patients treated with Sm-153 EDTMP (1mg/kg) over first 6 months of the current year were included in the study. Methods and Material: Clinical assessment, haematological assessment and assessment of quality of life with a mini questionnaire was done at baseline and at 6-12 weeks after Sm-153 EDTMP. Statistical analysis used: Data from questionnaires was entered in excel for import to SPSS. Means were compared using paired t test while proportions were compared using chi square test for proportions. Results: Of the 26 patients included in the study 19(73%) showed subjective improvement in pain. Statistically significant improvement in quality of life was observed within 6-12 weeks. Quality of life improved in all the patients who experienced pain relief. None of the patients developed severe haematological toxicity. Conclusions: In the availability of a Nuclear Medicine department, Sm-153EDTMP can be used in a well selected group of patients for utilization for bone pain relief even in the setting of peripheral, smaller cities located away from metropolitan cities. Advantages include long duration of effect, ease of administration, low toxicity and repeatability of doses. It can have a positive impact in quality of life of patients with advanced cancer.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran